Samuel Sia is an Associate Professor in the Department of Biomedical Engineering at Columbia University. His lab focuses on using microfluidics for global health diagnostics and for 3D tissue biology. He obtained his B.S. in Biochemistry at the University of Alberta, Ph.D. in Biophysics at Harvard University, and postdoctoral fellowship in Chemistry at Harvard University. He was a Howard Hughes Medical Institute Predoctoral Fellow, National Science and Engineering Council of Canada Predoctoral Fellow, and Canadian Institute of Health Postdoctoral Fellow. Since 2005, he has been a faculty member of Columbia University’s Biomedical Engineering department. His lab’s work has been supported by the NIH (NHLBI and NINR), NSF,
USAID/Grand Challenges Canada/Gates Foundation, Wallace H. Coulter Foundation, American Heart Association, and World Health Organization. He has been named one of the world’s top young innovators by MIT Technology Review. The PI’s work has garnered coverage from Nature, Science, JAMA, Washington Post, BBC, NPR, Voice of America, Science News, Popular Science, Chemical and Engineering News, and MIT Technology Review. He is a founder of Claros Diagnostics (a venture capital-backed diagnostics company acquired by Opko Health), Harlem Biospace (a biotech incubator funded by New York City Economic Development Corporation), and Junco Labs.